INFI Past Earnings image   This INFI past earnings page last updated 11/15/2022
INFI Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/14/2022-0.120
Q2 20228/9/2022-0.130
Q1 20225/3/2022-0.140
Q4 20213/29/2022-0.130
Q3 202111/2/2021-0.120
Q2 20217/27/2021-0.130
Q1 20215/13/2021-0.150
Q4 20203/16/2021-0.170
Q3 202011/9/2020-0.160
Q2 20207/30/2020-0.160
Q1 20205/11/2020-0.190
Q4 20193/3/2020-0.200
Q3 201910/30/2019-0.200
Q2 20197/30/2019-0.180
Q1 20195/7/2019-0.240
Q4 20183/14/2019-0.14
Q3 201811/5/20180.23
Q2 20188/7/2018-0.12
Q1 20185/8/2018-0.18
Q4 20173/15/2018-0.14
Q3 201711/7/2017-0.14
Q2 20178/3/2017-0.34
Q1 20175/9/2017-0.21
Q4 20163/14/2017-0.46
Q3 201611/9/2016-0.39
Q2 20168/9/2016-1.2
Q1 20165/4/2016-0.82
Q4 20152/23/2016-0.8
Q3 201511/5/20150.84
Q2 20158/6/2015-0.78
Q1 20155/6/2015-1.91
Q4 20142/24/2015-0.83
Q3 201411/6/20142.03
Q2 20148/5/2014-0.78
Q1 20145/6/2014-0.87
Q4 20132/25/2014-0.680
Q3 201311/7/2013-0.71
Q2 20138/8/2013-0.68
Q1 20135/7/2013-0.57
Q4 20123/5/2013-1.48
Q3 201211/6/20120.52
Q2 20128/7/2012-0.54
Q1 20125/8/2012-0.4
INFI Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/14/20220.00B
Q2 20228/9/20220.00B
Q1 20225/3/20220.00B
Q4 20213/29/20220.00B
Q3 202111/2/20210.00B
Q2 20217/27/20210.00B
Q1 20215/13/20210.00B
Q4 20203/16/20210.00B
Q3 202011/9/20200.00B
Q2 20207/30/20200.00B
Q1 20205/11/20200.00B
Q4 20193/3/20200.00B
Q3 201910/30/20190.00B
Q2 20197/30/20190.00B
Q1 20195/7/20190.00B
Q4 20183/14/2019146000
Q3 201811/5/201822.00M
Q2 20188/7/2018NA
Q1 20185/8/2018NA
Q4 20173/15/2018NA
Q3 201711/7/20176.00M
Q2 20178/3/2017NA
Q1 20175/9/2017NA
Q4 20163/14/2017NA
Q3 201611/9/2016NA
Q2 20168/9/20169.47M
Q1 20165/4/20169.26M
Q4 20152/23/20169.08M
Q3 201511/5/201590.74M
Q2 20158/6/20154.88M
Q1 20155/6/20154.36M
Q4 20142/24/20154.36M
Q3 201411/6/2014160.60M
Q2 20148/5/2014NA
Q1 20145/6/2014NA
Q4 20132/25/2014NA
Q3 201311/7/2013NA
Q2 20138/8/2013NA
Q1 20135/7/2013NA
Q4 20123/5/2013NA
Q3 201211/6/2012NA
Q2 20128/7/201221.91M
Q1 20125/8/201225.20M
Quotes delayed 20 minutes

Email EnvelopeFree INFI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Infinity Pharmaceuticals (INFI) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

INGN Past Earnings
INMB Past Earnings
INNV Past Earnings
INO Past Earnings
INSM Past Earnings
INSP Past Earnings
INVA Past Earnings
INVO Past Earnings
INZY Past Earnings
IONS Past Earnings

INFI Past Earnings Q&A

What was the best and worst INFI past earnings results?
For Infinity Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest INFI past earnings result in our data set was 2.03/share posted in Q3 2014, while the lowest was in Q1 2015 when INFI posted -1.91/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2014 when INFI reported 160.60M in revenue, while the quarter with the lowest revenue in our data set was Q2 2018 at NA of revenue.

  Suggested answer: There are 43 INFI past earnings results in our data set.

On this page we presented the INFI past earnings date information for Infinity Pharmaceuticals. Reviewing that INFI Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2014, when INFI posted gaap of 2.03/share. Meanwhile the lowest INFI past earnings result was in Q1 2015, when INFI posted gaap of -1.91/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2014 when INFI reported 160.60M in revenue, while the smallest revenue quarter was Q2 2018 when INFI reported NA in revenue.

Any self directed investor doing their due diligence on INFI or any other given stock can benefit from researching all of the Infinity Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Infinity Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for INFI. Thanks for visiting, and the next time you need to research INFI past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: GDRX shares outstanding history, L Options Chain, Institutional Holders of PWRM.


INFI Past Earnings | | Copyright © 2020 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.